首页> 外国专利> CENTRAL MEMORY T-CELLS OF AGAINST THIRD PARTY, METHODS FOR THEIR PRODUCTION AND THEIR APPLICATION IN TRANSPLANTATION AND DISEASES TREATMENT

CENTRAL MEMORY T-CELLS OF AGAINST THIRD PARTY, METHODS FOR THEIR PRODUCTION AND THEIR APPLICATION IN TRANSPLANTATION AND DISEASES TREATMENT

机译:第三方的中央记忆T细胞,其生产方法及其在移植和疾病治疗中的应用

摘要

FIELD: medicine.;SUBSTANCE: group of inventions can be used to obtain an isolated cell population comprising non-graft-versus-host (GVHD) inducing cells against a third party having a central memory T-lymphocyte phenotype (Tcm). The method comprises: (a) treatment of non-sticking peripheral blood mononuclear cells (PBMCs) with an agent capable of depleting CD4+ and/or CD56+ cells to produce CD8+T cells; (b) contacting of the said CD8+ T cells with a third-party antigen or antigens in the presence of IL-21 for 12 hours to 5 days to enrich the antigen-reactive cells; and (c) culturing of the said cells obtained in step (b) in the presence of IL-21, IL-15 and IL-7 in an antigen-free medium for 5-20 days to allow proliferation of cells having the said T-lymphocyte phenotype central memory (Tcm), thereby obtaining an isolated population of cells. The group of inventions also relates to versions of the method for production of the above cells and to methods for treatment of a subject in need of cell or tissue transplantation as well as transplantation of immature hematopoietic cells. These cells against the third party have a central memory T-lymphocyte phenotype, including CD3+, CD8+, CD62L+, CD45RA-, CD45RO+ signature, wherein at least 50% of the isolated cell population is CD3+CD8+ cells.;EFFECT: application of this group of inventions allows to use a population of cells having a central memory T-lymphocyte phenotype and capable of homing to the lymph nodes after transplantation to induce tolerance.;22 cl, 4 ex, 6 tbl, 29 dwg
机译:领域:一组发明可以用于获得分离的细胞群,该细胞群包含针对具有中央记忆T淋巴细胞表型(Tcm)的第三方的非移植物抗宿主(GVHD)诱导细胞。该方法包括:(a)用能够消耗CD4 +和/或CD56 +细胞以产生CD8 + T细胞的试剂处理非粘性外周血单核细胞(PBMC); (b)在IL-21存在下,使所述CD8 + T细胞与一种或多种第三方抗原接触12小时至5天,以富集抗原反应性细胞; (c)将步骤(b)中获得的所述细胞在IL-21,IL-15和IL-7存在下在无抗原培养基中培养5-20天,以使具有所述T的细胞增殖。 -淋巴细胞表型中央记忆(Tcm),从而获得分离的细胞群。本发明组还涉及用于生产上述细胞的方法的形式以及用于治疗需要细胞或组织移植以及未成熟造血细胞移植的受试者的方法。这些针对第三方的细胞具有中央记忆T淋巴细胞表型,包括CD3 + ,CD8 + ,CD62L + ,CD45RA -,CD45RO + 签名,其中至少50%的分离细胞群是CD3 + CD8 +细胞。;效果:应用这组发明可以使用具有以下特征的细胞群:中枢记忆T淋巴细胞表型,能够在移植后归巢到淋巴结以诱导耐受。22cl,4 ex,6 tbl,29 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号